Mesenchymale Stammzelle für Topische oder Systemische Immunmodulatorische Therapie für Hidradenitis Suppurativa bei Menschen
EP4813399
30. September 2026
Anmelder: Lietuvos sveikatos mokslu universitetas 🇱🇹
Details
- Veröffentlichungs-Nr.
- EP4813399
- Anmeldetag
- 28. März 2025
- Veröffentlichung
- 30. September 2026
- Rechtsraum
- EP
Abstract
This present invention relates to novel uses for mesenchymal stem cells, in particular to the use of mesenchymal stem cells in the treatment of autoinflammatory skin disease hidradenitis suppurativa. Preferably, allogeneic human placenta mesenchymal stem cells are used, that can be administered topically and/or by intravenous, intraarterial, intralesional or subcutaneous administration. In some embodiments, the mesenchymal stem cells are used in combination with another therapeutic agent.
Anmelder
- Firma
- Lietuvos sveikatos mokslu universitetas
- Land
- 🇱🇹 Litauen